These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 2529125

  • 1. Identification of interleukin 4 receptor-associated proteins and expression of both high- and low-affinity binding on human lymphoid cells.
    Foxwell BM, Woerly G, Ryffel B.
    Eur J Immunol; 1989 Sep; 19(9):1637-41. PubMed ID: 2529125
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of interleukin 4 receptor expression on human lymphoid cells by cyclosporin.
    Foxwell BM, Woerly G, Ryffel B.
    Eur J Immunol; 1990 May; 20(5):1185-8. PubMed ID: 2141571
    [Abstract] [Full Text] [Related]

  • 3. Regulation of interleukin-12 receptor beta1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells.
    Wu C, Warrier RR, Wang X, Presky DH, Gately MK.
    Eur J Immunol; 1997 Jan; 27(1):147-54. PubMed ID: 9022011
    [Abstract] [Full Text] [Related]

  • 4. Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein.
    Bich-Thuy LT, Dukovich M, Peffer NJ, Fauci AS, Kehrl JH, Greene WC.
    J Immunol; 1987 Sep 01; 139(5):1550-6. PubMed ID: 3040856
    [Abstract] [Full Text] [Related]

  • 5. Interleukin 4 (BSF-1) induces growth in resting murine CD8 T cells triggered via cross-linking of T3 cell surface structures.
    Miethke T, Schmidberger R, Heeg K, Gillis S, Wagner H.
    Eur J Immunol; 1988 May 01; 18(5):767-72. PubMed ID: 2967763
    [Abstract] [Full Text] [Related]

  • 6. IL-12 receptor. I. Characterization of the receptor on phytohemagglutinin-activated human lymphoblasts.
    Chizzonite R, Truitt T, Desai BB, Nunes P, Podlaski FJ, Stern AS, Gately MK.
    J Immunol; 1992 May 15; 148(10):3117-24. PubMed ID: 1578138
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the cell surface receptors for human B cell growth factor of 12,000 molecular weight.
    Mehta SR, Grant SR, Maizel AL.
    J Immunol; 1986 Oct 01; 137(7):2210-4. PubMed ID: 3093567
    [Abstract] [Full Text] [Related]

  • 8. Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cells.
    Obiri NI, Puri RK.
    Oncol Res; 1994 Oct 01; 6(9):419-27. PubMed ID: 7703528
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS, Berger AE, Ware CF.
    J Immunol; 1990 Apr 01; 144(7):2582-91. PubMed ID: 1969453
    [Abstract] [Full Text] [Related]

  • 10. A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes.
    Garrone P, Djossou O, Galizzi JP, Banchereau J.
    Eur J Immunol; 1991 Jun 01; 21(6):1365-9. PubMed ID: 1828424
    [Abstract] [Full Text] [Related]

  • 11. Selective induction of growth factor production and growth factor receptor expression by different signals to a single T cell.
    Rojo JM, Kerner JD, Janeway CA.
    Eur J Immunol; 1989 Nov 01; 19(11):2061-7. PubMed ID: 2574679
    [Abstract] [Full Text] [Related]

  • 12. Regulation of interleukin-2 and interleukin-4 receptor expression in human and ape lymphoid cell lines.
    Guizani L, Lang P, Stancou R, Bertoglio J.
    Lymphokine Cytokine Res; 1993 Feb 01; 12(1):25-32. PubMed ID: 8457629
    [Abstract] [Full Text] [Related]

  • 13. Interleukin 4 receptors on normal human B lymphocytes: characterization and regulation.
    Zuber CE, Galizzi JP, Vallé A, Harada N, Howard M, Banchereau J.
    Eur J Immunol; 1990 Mar 01; 20(3):551-5. PubMed ID: 2318249
    [Abstract] [Full Text] [Related]

  • 14. Identification of a novel protein capable of interacting with the IL-3 receptor.
    Morel PA, Schreurs J, Townsend K, Gross M, Chiller JM, Tweardy DJ.
    J Immunol; 1991 Apr 01; 146(7):2295-304. PubMed ID: 2005398
    [Abstract] [Full Text] [Related]

  • 15. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
    Weil-Hillman G, Voss SD, Fisch P, Schell K, Hank JA, Sosman JA, Sugamura K, Sondel PM.
    Cancer Res; 1990 May 01; 50(9):2683-91. PubMed ID: 1691679
    [Abstract] [Full Text] [Related]

  • 16. IL-2 receptors on circulating natural killer cells and T lymphocytes. Similarity in number and affinity but difference in transmission of the proliferation signal.
    Ben Aribia MH, Moiré N, Métivier D, Vaquero C, Lantz O, Olive D, Charpentier B, Senik A.
    J Immunol; 1989 Jan 15; 142(2):490-9. PubMed ID: 2783438
    [Abstract] [Full Text] [Related]

  • 17. Induction of high-affinity paf receptor expression during T cell activation.
    Calabresse C, Nguer MC, Pellegrini O, Benveniste J, Richard Y, Thomas Y.
    Eur J Immunol; 1992 Jun 15; 22(6):1349-55. PubMed ID: 1350980
    [Abstract] [Full Text] [Related]

  • 18. Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hemopoietic and nonhemopoietic cells.
    Lowenthal JW, Castle BE, Christiansen J, Schreurs J, Rennick D, Arai N, Hoy P, Takebe Y, Howard M.
    J Immunol; 1988 Jan 15; 140(2):456-64. PubMed ID: 2961813
    [Abstract] [Full Text] [Related]

  • 19. Regulation of LFA-1-mediated T cell adhesion by CD4.
    Mazerolles F, Hauss P, Barbat C, Figdor CG, Fischer A.
    Eur J Immunol; 1991 Apr 15; 21(4):887-94. PubMed ID: 1826886
    [Abstract] [Full Text] [Related]

  • 20. Biological function and distribution of human interleukin-12 receptor beta chain.
    Wu CY, Warrier RR, Carvajal DM, Chua AO, Minetti LJ, Chizzonite R, Mongini PK, Stern AS, Gubler U, Presky DH, Gately MK.
    Eur J Immunol; 1996 Feb 15; 26(2):345-50. PubMed ID: 8617302
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.